Health Payer Intelligence January 22, 2021
Kelsey Waddill

Payers will hone their telehealth and gene therapy strategies in 2021 and will also refine their forecasting capabilities.

In 2021, payers will expand upon lessons learned about telehealth and gene therapy in 2020 as they implement their strategies in the new year.

Listen to the full podcast to hear more details. And don’t forget to subscribe on iTunes, Spotify, or Google Podcasts.

Now that telehealth utilization has become more widespread, payers will work toward integrating virtual care and telehealth.

Over the course of the pandemic, payers had the opportunity to use telehealth and virtual care in a variety of contexts. As a result, the healthcare system has more data on what uses are best suited to telehealth.

For example, the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Health IT, Insurance, Patient / Consumer, Payer, Pharma / Biotech, Precision Medicine, Provider, Technology, Telehealth
Delivering the Right Approach for Virtual Primary Care: 3 Key Insights
Trends in telehealth: Expanding the role of nurses in virtual care
Telehealth boosts quality metrics while nudging up spending
Telehealth use led to modest care improvements, spending increases
From Option to Imperative: A Roadmap for Telehealth Adoption

Share This Article